About CRAB

CRAB’s approach to preventing and curing cancer is to collaborate with investigators to design, implement, and execute clinical trials such that reliable and replicable results are obtained. Clinical trials are extremely expensive and will guide new therapeutics, prevention programs and standards of care. Thus we contribute our expertise from the design of the study and protocol development through to the final analysis and publication of results.

Our highly trained cancer research specialists, together with collaborators, leverage CRAB’s proprietary customizable database and electronic data capture system, to provide seamless data collection, query tracking, and resolution so that analyses follow immediately upon study completion.

CRAB Knows Cancer

• CRAB is a 501(c)(3) non-profit organization, founded in 1997 by internationally renowned biostatistician John Crowley, Ph.D. to perform unique and critical roles in the battle against cancer.
• Research teams at CRAB, under the direction of President and CEO Antje Hoering, Ph.D., lead the development of statistical methods and technologies to optimize cancer research and the clinical trial process.
• SWOG continues to be our primary partner and collaborator, but CRAB’s clinical trial services extend to other consortia, research institutes and pharmaceutical companies.
• We possess expertise and provide data in cancer staging, historical controls, high dimensional genomic correlatives and targeted designs and therapies.
• CRAB is mission driven - our goal is to prevent and cure cancer. We are committed to assuring the highest research quality and integrity so that patients on our trials and others who follow them will benefit from the knowledge gained.
• We have the integrity and diversity of expertise needed to successfully advance clinical trials of promising new therapies.
• CRAB has pioneered the development of statistical methods and technologies to optimize cancer research.